Kodiak Sciences director granted 17,731 stock options
Kodiak Sciences Inc. director Robert Profusek received a grant of stock options covering 17,731 shares of common stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Kodiak Sciences Inc. director Robert Profusek received a grant of stock options covering 17,731 shares of common stock. The options have an exercise price of $38.96 per share and expire on June 29, 2036.
All 17,731 option shares vest in full on the earlier of June 30, 2027 or one day before the company’s next annual meeting after the grant date, as long as he continues serving on the board through that vesting date. Following this grant, he holds 17,731 derivative securities directly.
Insider Trade Summary
Grant/Award: 17,731 shares
Grant/Award
1 txn
Insider
PROFUSEK ROBERT
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 17,731 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 17,731 contracts (Direct)
Footnotes (1)
- F1. One hundred percent (100%) of the shares subject to the option shall vest upon the earlier of June 30, 2027 or one (1) day prior to the Issuer's next annual meeting occurring after the grant date, in each case, provided the Reporting Person continues to serve as a member of the Issuer's board of directors through the applicable vesting date.
Key Figures
Option shares granted: 17,731 shares
Exercise price: $38.96 per share
Expiration date: June 29, 2036
+3 more
6 metrics
Option shares granted
17,731 shares
Stock Option (Right to Buy) grant to director
Exercise price
$38.96 per share
Stock option exercise price
Expiration date
June 29, 2036
Stock option expiration
Underlying common shares
17,731 shares
Common stock underlying the option
Total derivative securities held
17,731 options
Holdings following transaction
Vesting trigger date
June 30, 2027
Earlier of this date or day before next annual meeting
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, vesting, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 38.9600"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-29T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"shares subject to the option shall vest upon the earlier of June 30, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
underlying security financial
"underlying_security_title: Common Stock"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Kodiak Sciences (KOD) report for Robert Profusek?
Kodiak Sciences reported that director Robert Profusek received a grant of stock options. The award covers 17,731 shares of common stock and is structured as a compensation-related grant, not an open-market purchase or sale of Kodiak Sciences shares.
How many Kodiak Sciences (KOD) stock options were granted to Robert Profusek?
Robert Profusek was granted stock options covering 17,731 shares of Kodiak Sciences common stock. These options give him the right to buy the same number of shares in the future, subject to vesting conditions and the stated exercise price and expiration date.
What is the exercise price and expiration date of the Kodiak Sciences (KOD) options?
The stock options granted to Robert Profusek have an exercise price of $38.96 per share and expire on June 29, 2036. This means he may purchase Kodiak Sciences shares at $38.96 if the options are vested and exercised before expiration.
When do Robert Profusek’s Kodiak Sciences (KOD) options vest?
All 17,731 stock option shares vest 100% on the earlier of June 30, 2027 or one day before Kodiak Sciences’ next annual meeting after the grant date. Vesting requires that he continue serving as a member of the board through the applicable vesting date.
Is Robert Profusek’s Form 4 transaction in Kodiak Sciences (KOD) a purchase or a grant?
The Form 4 transaction for Robert Profusek is classified as a grant or award acquisition of stock options. It reflects a compensation-related award from Kodiak Sciences, not an open-market purchase, and is coded as an “A” transaction for an option grant.
How many Kodiak Sciences (KOD) derivative securities does Robert Profusek hold after the grant?
After this option grant, Robert Profusek holds 17,731 derivative securities related to Kodiak Sciences, all from this stock option award. These options correspond to 17,731 underlying common shares, contingent on vesting and any future exercise decisions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
